Total: £ 56.28
2024-11-19 | Pages: 144 | Tables: 251
The global market for Metronidazole Capsule was estimated to be worth US$ 38 million in 2023 and is forecast to a readjusted size of US$ 65 million by 2030 with a CAGR of 8.0% during the forecast period 2024-2030 North American market for Metronidazo...
2024-11-19 | Pages: 136 | Tables: 259
The global market for Metronidazole Tablet was estimated to be worth US$ 41 million in 2023 and is forecast to a readjusted size of US$ 64 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030 North American market for Metronidazol...
2024-11-19 | Pages: 123 | Tables: 236
The global market for Nano Magnetic Beads was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Nano Magnetic Beads w...
2024-11-19 | Pages: 106 | Tables: 180
A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable...
2024-11-19 | Pages: 102 | Tables: 209
The global market for Primary Tumor Cell Culture was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Primary Tumor ...
2024-11-19 | Pages: 108 | Tables: 207
The global market for Cancer Cell Media was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Cancer Cell Media was v...
2024-11-19 | Pages: 106 | Tables: 178
The global market for Image Guided Therapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billi...
2024-11-19 | Pages: 115 | Tables: 176
The global market for Prolotherapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Prolotherapy was valued at $...
2024-11-19 | Pages: 128 | Tables: 242
The global market for Medicinal Cannabis Compounding was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is ...
2024-11-19 | Pages: 131 | Tables: 210
The global market for Enzyme Markers was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Enzyme Markers was valued ...
2024-11-19 | Pages: 131 | Tables: 252
The global market for Stool Softener was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Stool Softener was valued ...
2024-11-19 | Pages: 104 | Tables: 178
The global market for STD Tests was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for STD Tests was valued at $ milli...
2024-11-19 | Pages: 97 | Tables: 210
The global market for Hepatoprotective Supplement was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Hepatoprotect...
2024-11-19 | Pages: 110 | Tables: 186
The global market for Ovarian Reserve Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Ovarian Reserve T...
2024-11-19 | Pages: 127 | Tables: 230
The global market for Paclitaxel and Docetaxel was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Paclitaxel and D...